Dąbrowska, M.; Jaroszewicz, J.; Sitko, M.; Janocha-Litwin, J.; Zarębska-Michaluk, D.; Janczewska, E.; Lorenc, B.; Tudrujek-Zdunek, M.; Parfieniuk-Kowerda, A.; Klapaczyński, J.;
et al. The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies. Cancers 2024, 16, 3114.
https://doi.org/10.3390/cancers16173114
AMA Style
Dąbrowska M, Jaroszewicz J, Sitko M, Janocha-Litwin J, Zarębska-Michaluk D, Janczewska E, Lorenc B, Tudrujek-Zdunek M, Parfieniuk-Kowerda A, Klapaczyński J,
et al. The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies. Cancers. 2024; 16(17):3114.
https://doi.org/10.3390/cancers16173114
Chicago/Turabian Style
Dąbrowska, Maria, Jerzy Jaroszewicz, Marek Sitko, Justyna Janocha-Litwin, Dorota Zarębska-Michaluk, Ewa Janczewska, Beata Lorenc, Magdalena Tudrujek-Zdunek, Anna Parfieniuk-Kowerda, Jakub Klapaczyński,
and et al. 2024. "The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies" Cancers 16, no. 17: 3114.
https://doi.org/10.3390/cancers16173114
APA Style
Dąbrowska, M., Jaroszewicz, J., Sitko, M., Janocha-Litwin, J., Zarębska-Michaluk, D., Janczewska, E., Lorenc, B., Tudrujek-Zdunek, M., Parfieniuk-Kowerda, A., Klapaczyński, J., Berak, H., Socha, Ł., Dobracka, B., Dybowska, D., Mazur, W., Ważny, Ł., & Flisiak, R.
(2024). The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies. Cancers, 16(17), 3114.
https://doi.org/10.3390/cancers16173114
